Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Dystrophin immunogenicity and...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Dystrophin immunogenicity and requirement in myogenic cells: Paradigm shift in gene therapy for DMD

Bibliographic Details
Published in:Clinical and Translational Medicine
Main Author: Dariusz C. Górecki
Format: Article
Language:English
Published: Wiley 2022-11-01
Online Access:https://doi.org/10.1002/ctm2.1122
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1002/ctm2.1122

Similar Items

  • Long-term dystrophin restoration supports development of splice correction therapy for DMD patients with exon 2 duplications
    by: Thomas C. Roberts
    Published: (2023-12-01)
  • Ubiquitination-targeted therapies improve BMD iPSC myogenic cell engraftment and dystrophin expression in vivo
    by: Muchen Liu, et al.
    Published: (2025-09-01)
  • Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD
    by: Britt Hanson, et al.
    Published: (2022-12-01)
  • Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method
    by: Jean-Paul Iyombe-Engembe, et al.
    Published: (2016-01-01)
  • Restoration of brain dystrophin using tricyclo-DNA ASOs restores neurobehavioral deficits in DMD mice
    by: Muthukumar Karuppasamy, et al.
    Published: (2023-06-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs